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An innovative approach for manipulating glycosyltransferase-catalyzed glycosylation has now been devel-
oped (Truman et al.). Created using a domain-swapping strategy, these chimeric glycotransferases have
predictable substrate specificity and may lead to the breakthrough developments in the preparation of
carbohydrate-containing molecules of biological interest.The major advancements in biological
sciences over the last century have been
made in the protein and the nucleic acids
fields of research, and, although continued
contributions have been made to the
understanding of carbohydrates biology,
thefield isnowgainingmomentum.Carbo-
hydrates often play mysterious but indis-
pensable roles in diverse biological events
(Dwek, 1996); however, the structural
complexity of carbohydrates has signifi-
cantly hindered the progress. In order to
reveal the insights of carbohydrates’ func-
tion, the manipulation of sugar compo-
nents on aglycons of interest, a strategy
knownasglycodiversification (Thibodeaux
et al., 2007), glycorandomization (Yang
et al., 2004), or neoglycorandomization
(Langenhan et al., 2005), is often needed.
Among the reactions involved in glycodi-
versification, glycosylation is the most
pivotal step. Glycosylation is typically
accomplished via chemical (Demchenko,
2008) or enzymatic (Melanc¸on et al.,
2006; Zhang et al., 2006) methods. While
chemical glycosylation may be applicable
to diverse natural and non-natural glycosyl
donors and aglycons, the syntheses of
these donors and aglycons could be diffi-
cult to conduct and accomplish. In addi-
tion, the scale-up production of desired
glycoconjugates could be complicated by
the additional protection and de-protec-
tion steps. In contrast, enzymatic glycosyl-
ation using glycosyltransferases (GTs)
and the corresponding glycosyl donors
appears to be more suitable for scale-up
production of glycoconjugates, using, for
example, bioengineering and fermentation
processes. Nevertheless, the substrate
specificity of GTs often significantly lowers
the efficiency of incorporating foreign
carbohydrates. Exploring intrinsic or engi-
neered GTs’ substrate promiscuity offers
a possible step forward toward solvingthis problem, albeit impededby the current
inability to fully predict substrate accept-
ability of GTs.
A report focused on using a domain-
swappingstrategybasedon thesequence
comparison and the domain analysis of
GTs now provides a rationale-based
prediction of the substrate specificity of
the designed chimeric GTs (Truman
et al., 2009). In general, GTs contain two
domains: the domain for binding of nucle-
oside diphospho-sugar (NDP-sugar),
which functions as the glycosyl donors,
and the domain for binding of aglycons
(glycosyl acceptor). Truman et al. (2009)
construct chimeric GTs by swapping the
N- and C- domains of two natural GTs
and evaluate their enzymatic behavior.
Initial studies of these native and chimeric
GTs confirm that the N-terminal domain
controls acceptor (aglycon) binding, while
the C-terminal domain controls sugar
(from NDP-sugar) binding. The authors
further explore the domain-swapping
strategy by focusing on GtfAH1 as a
powerful example of chimeric glycosyl-
transferases. The chimeric GtfAH1 con-
tains N-terminal domain from GtfA
and C-terminal domain from Orf1. GtfA
and Orf1 transfer epi-vancosamine and
N-acetylglucosamine (GlcNAc) onto des-
vancosaminyl vancomycin (DVV) and
teicoplanin glucosaminyl-pseudoaglycon,
respectively, and are highly specific
toward their native substrates. The
chimeric GtfAH1, however, shows much
more tolerance with different substrates
and transfer sGlcNAc onto various glyco-
peptides acceptors with comparable ef-
fiency in comparison to the parent GTs.
Glycodiversification using a biological
approach is a power tool for elucidating
the structure activity relationship (SAR)
that is essential for making carbohy-
drate-containing biomolecules with prac-Chemistry & Biology 16, June 26, 200
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swapping strategy offers a rare opportu-
nity of predicting the substrate specificity
of the engineered GTs, which could serve
as the foundation for biological glycodi-
versification. Coupledwith X-ray structure
studies, it may be even possible to intro-
duce unnatural sugars onto the aglycons
of interest. With all the exciting accom-
plishments, several technical aspects
may need to be addressed prior to the
development of mature technology. First,
it requires a collection of C-terminal
domains from various GTs in order to
take full advantage of biological glycodi-
versification. For example, it would be
extremely important and interesting to
reproduce the same efficiency of chimeric
GTs that can transfer L-sugars, deoxysu-
gars, aminosugars, and sugars with
branched-chain. Second, it is also critical
to demonstrate the feasibility of glycosy-
lating aglycons other than glycopeptides
with the chimeric GTs. This aim, presum-
ably, canbeaccomplishedwith thecollec-
tion of N-terminal domains from various
GTs. Finally, it will be crucial to examine
the assumption that the ‘‘linker’’ se-
quences for the connection of N- and
C- terminal domains can be applicable or
universal to various classes of GTs.
Chemical glycodiversification may be
more suitable for library construction of
glycoconjugates with non-natural struc-
tural components, needed for further
detailed SAR investigations. Neverthe-
less, the chemical syntheses represent
a great hurdle for implementing such an
approach in generating desired products
on industrial scale. The work presented
by Truman et al. (2009) is a significant
step forward in developing methods for
the large-scale preparation of carbohy-
drate-containing biomolecules. Further
results regarding the above-mentioned9 ª2009 Elsevier Ltd All rights reserved 579
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Previewstechnical issues of employing the domain
swapping approachwill certainly corrobo-
rate the merits of biological glycodiversifi-
cation, and enable the practical and scale-
up production of glycoconjugates free of
the limitations imposed by nature.
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which impedes bioinformatic studies.
However, approaches based on structur-
ally informed sequence searches starting
from 2OG oxygenases with known func-
tions have led to the discovery of human
orthologs, including enzymes with impor-
tant biomedical functions.
In 1993, Borst and coworkers discov-
ered that the DNA of African trypano-
somes, protist parasites that causeAfrican
sleeping sickness, contained the unusual
base b-D-glucosylhydroxymethyl-uracil,
termed base J (Figure 1Ai). Their efforts
to understand the nature of this modifica-
tion and its role in expression led to the
proposal of two trypanosomatid J-binding
proteins JBP1 and JBP2 as thymidine
hydroxylases of the 2OG oxygenase
family (Yu et al., 2007). Starting fromstruc-
turally informed iterative sequence profile
searches using the JBP1 and JBP2 oxy-
genase domains, bioinformatic work from
Tahiliani et al. (2009) led to the prediction
of the three human enzymes TET1-3 as
Fe(II) and 2OG oxygenases that catalyze
5-methylcytosine hydroxylation (Fig-
ure 1Aii). TET1-3 appear to be part of the
wider TET/JBP fmaily, present minimally
in metazoans, fungi, and algae.
